Aethlon Medical AEMD
NASDAQ AEMD
$5.29 -0.29 (-5.20%)
At close: Nov 13, 2026 · 4:00 PM EST

Aethlon Medical (AEMD) Gains from Sales and Divestitures (2010 - 2024)

Updated

Aethlon Medical's Gains from Sales and Divestitures came in at -$24,406 for fiscal Q4 2024 (quarter ended Mar 31, 2024).

Analysis

Aethlon Medical (AEMD) Gains from Sales and Divestitures (2010 - 2024) Analysis & Trends

For FY2024 (ended Mar 31, 2024), Aethlon Medical's Gains from Sales and Divestitures was -$21,135.

  • Going back by fiscal year, Gains from Sales and Divestitures was -$142,121 in FY2023.
  • The fiscal Q4 2024 figure represents the highest quarterly Gains from Sales and Divestitures since fiscal Q2 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Aethlon Medical 5.33 Mn -18.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -24,406.00
Sep 30, 2022 -142,121.00
Sep 30, 2011 -13,065.00
Jun 30, 2011 -13,065.00
Jun 30, 2010 -13,065.00
API Access

Aethlon Medical Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=AEMD&period=max&api_key=YOUR_API_KEY